160 related articles for article (PubMed ID: 8835752)
1. Terbinafine-induced cholestatic liver disease.
Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
[TBL] [Abstract][Full Text] [Related]
2. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
[TBL] [Abstract][Full Text] [Related]
3. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
4. [Terbinafine-induced cholestatic liver injury].
Shiloah E; Horowiz M; Zecler E
Harefuah; 1997 Jul; 133(1-2):11-2, 80-1. PubMed ID: 9332048
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Paredes AH; Lewis JH
Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
[TBL] [Abstract][Full Text] [Related]
6. Cholestatic jaundice due to terbinafine.
Dwyer CM; White MI; Sinclair TS
Br J Dermatol; 1997 Jun; 136(6):976-7. PubMed ID: 9217846
[No Abstract] [Full Text] [Related]
7. Terbinafine-induced hepatic dysfunction.
Chambers WM; Millar A; Jain S; Burroughs AK
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
[TBL] [Abstract][Full Text] [Related]
8. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
[TBL] [Abstract][Full Text] [Related]
9. Systemic antifungal agents used to treat onychomycosis.
Katz HI
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S48-52. PubMed ID: 9594937
[No Abstract] [Full Text] [Related]
10. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
Kumar K; Gill A; Shafei R; Wright JL
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
[TBL] [Abstract][Full Text] [Related]
11. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
12. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
Ornstein DL; Ely P
J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis.
Lebwohl MG; Daniel CR; Leyden J; Mormon M; Shavin JS; Tschen E; Weiss J; Zone J
Int J Dermatol; 2001 May; 40(5):358-60. PubMed ID: 11555003
[No Abstract] [Full Text] [Related]
14. [Hepatitis attributed to the use of terbinafine].
Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
[TBL] [Abstract][Full Text] [Related]
15. [A patient treated with terbinafine. Intrahepatic biliary stasis is a severe adverse effect].
Ihre-Lundgren C; Frisell J; Bergman U
Lakartidningen; 1995 Mar; 92(11):1112-3. PubMed ID: 7700115
[No Abstract] [Full Text] [Related]
16. Onychomycosis treated with a short course of oral terbinafine.
Galimberti R; Kowalczuk A; Flores V; Squiquera L
Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
[No Abstract] [Full Text] [Related]
17. Terbinafine-induced hepatotoxicity.
Mejías Manzano MLÁ; Giráldez Gallego Á; Ontanilla Clavijo G; Sousa Martín JM
Gastroenterol Hepatol; 2019; 42(6):394-395. PubMed ID: 31167724
[No Abstract] [Full Text] [Related]
18. [Acute hepatitis associated with terbinafine].
Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
[TBL] [Abstract][Full Text] [Related]
19. Terbinafine hepatotoxicity. A case report and review of literature.
Zapata Garrido AJ; Romo AC; Padilla FB
Ann Hepatol; 2003; 2(1):47-51. PubMed ID: 15094707
[TBL] [Abstract][Full Text] [Related]
20. Isolated thrombocytopenia associated with oral terbinafine.
Tsai HH; Lee WR; Hu CH
Br J Dermatol; 2002 Sep; 147(3):627-8. PubMed ID: 12207625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
